Journal article icon

Journal article

Assessment of robustness against setup uncertainties using probabilistic scenarios in lung cancer: a comparison of proton with photon therapy

Abstract:

Objective: We compared the sensitivity of intensity modulated proton therapy (IMPT) and photon volumetric modulated arc therapy (VMAT) plans to setup uncertainties in locally advanced non-small cell lung cancer (NSCLC) using probabilistic scenarios.

Methods: Minimax robust (MM) and planning target volume (PTV) optimised IMPT and VMAT nominal plans were created with physical dose of 70 Gy in 35 fractions in 10 representative patients. Using population data of setup errors, a fractionated treatment course was simulated, summed (Dsum) and compared to the nominal plan. Three treatment-course simulations were done for each plan. Target robustness criteria were: dose deviation of ≤5% to clinical target volume (CTV) D98% and CTV V95% ≥ 99.9%. Voxelwise simulation repeatability was analysed using Bland–Altman plots. Acceptable limits of agreement were 2% of the prescription dose.

Results: All Dsum met target robustness criteria. While fraction VMAT and MM-IMPT doses were excellent, simulated fraction doses in PTV-IMPT were suboptimal. Almost all (>99%) of VMAT and MM-IMPT fraction doses met both target robustness criteria. For PTV-IMPT, only 96.9 and 80.3% of fractions met CTVD98% and V95% criteria respectively. Simulation repeatability was excellent (limits of agreement range: 0.41–1.1 Gy) with strong positive correlations.

Conclusions: When considering the whole treatment course, setup errors do not influence robustness irrespective of planning techniques used. However, on a fraction level, VMAT and MM-IMPT plans are superior compared to PTV-IMPT plans.

Advances in knowledge: Probabilistic analysis provides a fast and practical method for evaluating VMAT and IMPT plan sensitivity against setup uncertainty. VMAT and robust-optimised IMPT plans have comparable sensitivity to setup uncertainties in conventionally fractionated treatment for NSCLC.

Publication status:
Published
Peer review status:
Peer reviewed

Actions


Access Document


Files:
Publisher copy:
10.1259/bjr.20190584

Authors


More by this author
Role:
Author
ORCID:
0000-0002-5456-9273
More by this author
Division:
MSD
Department:
Oncology
Role:
Author
ORCID:
0000-0003-4672-5683


Publisher:
British Institute of Radiology
Journal:
British Journal of Radiology More from this journal
Volume:
93
Issue:
1107
Article number:
20190584
Publication date:
2020-02-04
Acceptance date:
2020-01-21
DOI:
EISSN:
1748-880X
ISSN:
0007-1285
Pmid:
31977241


Language:
English
Keywords:
Pubs id:
1083508
Local pid:
pubs:1083508
Deposit date:
2020-02-12

Terms of use



Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP